Aromatase inhibitors forfemaleinfertility treatment

Bibliography

• LERNER-GEVA L, KEINAN-BOKER L, BLUMSTEIN T et al.: Infertility, ovulation induction treatments and the incidence of breast cancer – a historical prospective cohort of Israeli women. Breast Cancer Res. Treat. (2006) 100(2):201-212.
   PubMedGoogle Scholar
• CARLIER P, CHOULIKA S, EFTHYMIOU ML: Clomiphene-exposed pregnancies – analysis of 39 information requests including 25 cases with known outcome. Therapie (1996) 51(5):532-536.
   PubMedGoogle Scholar
• COLE PA, ROBINSON CH: Mechanism and inhibition of cytochrome P-450 aromatase. J. Med. Chem. (1990) 33(11):2933-2942.
   PubMed Web of Science ®Google Scholar
• SEBASTIAN S, TAKAYAMA K, SHOZU M, BULUN SE: Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Mol. Endocrinol. (2002) 16(10):2243-2254.
   PubMedGoogle Scholar
• BULUN SE, LIN Z, IMIR G et al.: Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol. Rev. (2005) 57(3):359-383.
   PubMed Web of Science ®Google Scholar
• BUZDAR AU, ROBERTSON JF, EIERMANN W, NABHOLTZ JM: An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole and exemestane. Cancer (2002) 95(9):2006-2016.
   PubMed Web of Science ®Google Scholar
• WINER EP, HUDIS C, BURSTEIN HJ et al.: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J. Clin. Oncol. (2002) 20(15):3317-3327.
   PubMed Web of Science ®Google Scholar
• GEISLER J, HAYNES B, ANKER G, DOWSETT M, LONNING PE: Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J. Clin. Oncol. (2002) 20(3):751-757.
   PubMed Web of Science ®Google Scholar
• WEIL SJ, VENDOLA K, ZHOU J et al.: Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J. Clin. Endocrinol. Metab. (1998) 83(7):2479-2485.
   PubMed Web of Science ®Google Scholar
• VENDOLA K, ZHOU J, WANG J et al.: Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol. Reprod.. (1999) 61(2):353-357.
   PubMed Web of Science ®Google Scholar
• CORTINEZ A, DE CARVALHO I, VANTMAN D et al.: Hormonal profile and endometrial morphology in letrozole- controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil. Steril. (2005) 83(1):110-115.
   PubMed Web of Science ®Google Scholar
• NIKAS G, MAKRIGIANNAKIS A: Endometrial pinopodes and uterine receptivity. Ann. NY Acad. Sci. (2003) 997:120-123.
   PubMed Web of Science ®Google Scholar
• SHETTY G, KRISHNAMURTHY H, KRISHNAMURTHY HN, BHATNAGAR S, MOUDGAL RN: Effect of estrogen deprivation on the reproductive physiology of male and female primates. J. Steroid Biochem. Mol. Biol. (1997) 61(3-6):157-166.
   PubMed Web of Science ®Google Scholar
• MITWALLY M, CASPER RF: Aromatase inhibiton: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod. Biol. (2000) 10(12):244-247.
   Google Scholar
• MITWALLY MF, CASPER RF: Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil. Steril. (2001) 75(2):305-309.
   PubMed Web of Science ®Google Scholar
• MITWALLY MF, CASPER RF: Single-dose administration of an aromatase inhibitor for ovarian stimulation. Fertil. Steril. (2005) 83(1):229-231.
   PubMed Web of Science ®Google Scholar
• AL-OMARI WR, SULAIMAN WR, AL-HADITHI N: Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int. J. Gynaecol. Obstet. (2004) 85(3):289-291.
   PubMedGoogle Scholar
• ATAY V, CAM C, MUHCU M, CAM M et al.: Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J. Int. Med. Res. (2006) 34(1):73-76.
   PubMed Web of Science ®Google Scholar
• SOHRABVAND F, ANSARI S, BAGHERI M: Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum. Reprod. (2006) 21(6):1432-1435.
   PubMed Web of Science ®Google Scholar
• FISHER SA, REID RL, VAN VUGT DA, CASPER RF: A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil. Steril. (2002) 78(2):280-285.
   PubMed Web of Science ®Google Scholar
• FATEMI HM, KOLIBIANAKIS E, TOURNAYE H et al.: Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod. Biomed. Online (2003) 7(5):543-546.
   PubMedGoogle Scholar
• BAYAR U, TANRIVERDI HA, BARUT A et al.: Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil. Steril. (2006) 85(4):1045-1048.
   PubMedGoogle Scholar
• AL-FOZAN H, AL-KHADOURI M, TAN SL, TULANDI T: A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil. Steril. (2004) 82(6):1561-1563.
   PubMedGoogle Scholar
• KEMMANN E, JONES JR: Sequential clomiphene citrate-menotropin therapy for induction or enhancement of ovulation. Fertil. Steril. (1983) 39(6):772-779.
   PubMed Web of Science ®Google Scholar
• MITWALLY MF, CASPER RF: Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum. Reprod. (2003) 18(8):1588-1597.
   PubMed Web of Science ®Google Scholar
• KARAER O, VATANSEVER HS, ORUC S et al.: The aromatase inhibitor anastrozole is associated with favorable embryo development and implantation markers in mice ovarian stimulation cycles. Fertil. Steril. (2005) 83(6):1797-1806.
   PubMedGoogle Scholar
• DE ZIEGLER D: The dawning of the non-cancer uses of aromatase inhibitors in gynaecology. Hum. Reprod. (2003) 18(8):1598-1602.
   PubMedGoogle Scholar
• HEALEY S, TAN SL, TULANDI T, BILJAN MM: Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil. Steril. (2003) 80(6):1325-1329.
   PubMed Web of Science ®Google Scholar
• MITWALLY MF, CASPER RF: Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J. Soc. Gynecol. Investig. (2004) 11(6):406-415.
   PubMedGoogle Scholar
• GOSWAMI SK, DAS T, CHATTOPADHYAY R et al.: A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum. Reprod. (2004) 19(9):2031-2035.
   PubMed Web of Science ®Google Scholar
• MITWALLY MF, CASPER RF: Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil. Steril. (2002) 77(4):776-780.
   PubMed Web of Science ®Google Scholar
• SCHOOLCRAFT WS, MINJAREZ D, GARDNER DK: Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation. Fertil. Steril. (2002) 78(Suppl. 1):S234.
   PubMedGoogle Scholar
• GARCIA-VELASCO JA, MORENO L, PACHECO A et al.: The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil. Steril. (2005) 84(1):82-87.
   PubMed Web of Science ®Google Scholar
• OKTAY K, HOURVITZ A, SAHIN G et al.: Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J. Clin. Endocrinol. Metab. (2006) 91(10):3885-3890
   PubMed Web of Science ®Google Scholar
• BILJAN MM, HEMMINGS R, BRASSARD N: The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil. Steril. (2005) 84(Suppl.1):O-231, Abstract 1033.
   Google Scholar
• TULANDI T, MARTIN J, AL-FADHLI R et al.: Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril. (2006) 85(6):1761-1765.
   PubMed Web of Science ®Google Scholar